Sage Therapeutics Revenue 2013-2019 | SAGE

Sage Therapeutics annual/quarterly revenue history and growth rate from 2013 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Sage Therapeutics revenue for the quarter ending June 30, 2019 was $0.001B, a 99.03% decline year-over-year.
  • Sage Therapeutics revenue for the twelve months ending June 30, 2019 was $0.002B, a 98.21% decline year-over-year.
  • Sage Therapeutics annual revenue for 2018 was $0.09B, a INF% increase from 2017.
  • Sage Therapeutics annual revenue for 2017 was $0B, a NAN% decline from 2016.
  • Sage Therapeutics annual revenue for 2016 was $0B, a NAN% decline from 2015.
Sage Therapeutics Annual Revenue
(Millions of US $)
2018 $90
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
Sage Therapeutics Quarterly Revenue
(Millions of US $)
Q2 2019 $1
Q1 2019 $0
Q4 2018 $0
Q3 2018
Q2 2018 $90
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.507B $0.090B
SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product candidates include SAGE-547, SAGE-689 and SAGE-217. SAGE Therapeutics, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.196B 37.07
Astellas Pharma (ALPMY) Japan $26.780B 13.13
Takeda Pharmaceutical (TAK) Japan $26.201B 8.18
Grifols, S.A (GRFS) Spain $15.161B 19.34
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.716B 25.30
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.973B 21.51
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.886B 0.00
IPSEN SA ADR (IPSEY) France $8.634B 0.00
Catalent (CTLT) United States $8.127B 32.61
Jazz Pharmaceuticals (JAZZ) Ireland $7.726B 10.17
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.954B 17.81
FibroGen (FGEN) United States $3.877B 96.98
United Therapeutics (UTHR) United States $3.565B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.140B 11.25
Evotec AG (EVTCY) Germany $3.032B 41.51
Nektar Therapeutics (NKTR) United States $2.999B 0.00
Tilray (TLRY) Canada $2.849B 0.00
PTC Therapeutics (PTCT) United States $2.695B 0.00
Xencor (XNCR) United States $2.309B 50.35
Zogenix (ZGNX) United States $2.148B 0.00
Portola Pharmaceuticals (PTLA) United States $1.974B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.491B 14.95
Corcept Therapeutics (CORT) United States $1.468B 20.17
Heron Therapeutics (HRTX) United States $1.437B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.424B 23.49
Ironwood Pharmaceuticals (IRWD) United States $1.380B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.218B 0.00
ArQule (ARQL) United States $1.110B 0.00
Radius Health (RDUS) United States $1.059B 0.00
Aerie Pharmaceuticals (AERI) United States $1.034B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.919B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.828B 3.69
Endo (ENDP) Ireland $0.684B 1.20
TherapeuticsMD (TXMD) United States $0.661B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.636B 0.00
Indivior (INVVY) United States $0.575B 2.08
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.540B 0.00
Akebia Therapeutics (AKBA) United States $0.534B 0.00
Dermira (DERM) United States $0.482B 0.00
Concordia (CXRXF) Canada $0.479B 0.00
Aptorum Group (APM) China $0.464B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.457B 0.00
Translate Bio (TBIO) United States $0.443B 0.00
Dova Pharmaceuticals (DOVA) United States $0.429B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 19.43
ChemoCentryx (CCXI) United States $0.410B 0.00
ImmunoGen (IMGN) United States $0.409B 0.00
Flexion Therapeutics (FLXN) United States $0.407B 0.00
Siga Technologies (SIGA) United States $0.405B 0.95
Organogenesis Holdings (ORGO) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.365B 0.00
CV Sciences (CVSI) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.323B 0.00
Xeris Pharmaceuticals (XERS) United States $0.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.290B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.280B 0.00
CannTrust Holdings (CTST) Canada $0.277B 0.00
Lannett Co Inc (LCI) United States $0.277B 2.69
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
DURECT (DRRX) United States $0.263B 0.00
OptiNose (OPTN) United States $0.263B 0.00
Recro Pharma (REPH) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.246B 0.00
Ocular Therapeutix (OCUL) United States $0.218B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.185B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 29.26
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.155B 0.00
GlycoMimetics (GLYC) United States $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
Generex Biotechnology (GNBT) United States $0.137B 0.00
Majesco Entertainment (PTE) United States $0.133B 0.00
Jounce Therapeutics (JNCE) United States $0.123B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
MEI Pharma (MEIP) United States $0.120B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.114B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.111B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.101B 0.00
Cardiome Pharma (CORV) Canada $0.097B 0.00
Mast Therapeutics (SVRA) United States $0.096B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.94
Genocea Biosciences (GNCA) United States $0.083B 0.00
MediWound (MDWD) Israel $0.080B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.078B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
Otonomy (OTIC) United States $0.072B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 589.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Capnia (SLNO) United States $0.060B 0.00
Lipocine (LPCN) United States $0.060B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.040B 0.00
CTI BioPharma (CTIC) United States $0.040B 0.00
Aclaris Therapeutics (ACRS) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Melinta Therapeutics (MLNT) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.023B 0.00
IsoRay (ISR) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.44
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00